Article

Pharmacy Times: Week of February 22 Lineup

This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.

This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week, including:

  • A video interview with J. David Robertson, the director of University of Missouri Research Reactor (MURR), on how a new collaboration between MURR and Advanced Accelerator Applications International will help to develop a targeted therapy for certain types of cancerous tumors.
  • An article from the recent Society for Advancing Business Editing and Writing Healthcare 2021 virtual symposium, which discusses the main challenges surrounding COVID-19 vaccination—increasing vaccine production and delivery. The presentation noted that the faster people are vaccinated, the fewer opportunities there will be for variant versions of COVID-19 to spread and for more variants to emerge.

Related Videos
TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC
Image Credit: © Krakenimages.com - stock.adobe.com
Image Credit: © Cavan - stock.adobe.com
Child with cancer -- Image credit: Alexis Scholtz/peopleimages.com | stock.adobe.com
Image Credit: © Rawpixel.com - stock.adobe.com
Image Credit: © RandyJay - stock.adobe.com
WCLC, lung cancer, NSCLC
MARIPOSA Study: Long-Term Outcomes and Next Steps for Amivantamab Plus Lazertinib in EGFR-Mutant NSCLC
The EMPOWER-Lung 1 Trial: Five-Year Outcomes of Cemiplimab Monotherapy in Advanced NSCLC